Article Information
History
- January 16, 2015.
Article Versions
- Version 1 (December 16, 2014 - 10:26).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Debora Fumagalli1*,
- David Gacquer3*,
- Françoise Rothé1*,
- Anne Lefort3,
- Frederick Libert3,
- David Brown1,
- Naima Kheddoumi1,
- Adam Shlien8,
- Tomasz Konopka3,
- Roberto Salgado1,
- Denis Larsimont2,
- Kornelia Polyak6,
- Karen Willard-Gallo7,
- Christine Desmedt1,
- Martine Piccart1,
- Marc Abramowicz5,
- Peter J Campbell8,
- Christos Sotiriou1* and
- Vincent Detours3,4,*
- 1 Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125 - 1000 Brussels, Belgium
- 2 Department of Pathology, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125 - 1000 Brussels, Belgium
- 3 IRIBHM, Université Libre de Bruxelles (ULB),
- 4 WELBIO, Route de Lennik, 808 - 1070 Brussels, Belgium
- 5 Department of Genetics, Hôpital Erasme, Route de Lennik, 808 - 1070 Brussels, Belgium
- 6 Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA
- 7 Molecular Immunology Unit, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125 - 1000 Brussels, Belgium
- 8 Cancer Genetics and Genomics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK
- ↵Vincent Detours, IRIBHM, Université Libre de Bruxelles (ULB), WELBIO, Route de Lennik, 808, 1070 Brussels, Belgium, Email Address: vdetours{at}ulb.ac.be Phone: +32 2 555 4220, Fax: +32 2 555 4655
↵* Contributed equally to this work.